Hologic Announces Financial Results for Third Quarter of Fiscal 2015

Go back to Hologic Announces Financial Results for Third Quarter of Fiscal 2015

Canaccord Genuity Raises Price Target on Hologic (HOLX) Following 3Q Beat and FY15 Guidance Raise

July 30, 2015 10:49 AM EDT

Canaccord Genuity reiterated a Buy rating on Hologic (NASDAQ: HOLX), and raised the price target to $45.00 (from $40.00), following FQ3 results. Adjusted EPS of $0.43 beat the Street's $0.39 estimate. Revenues of $693.9M beat consensus estimates of $654M. HOLX raised FY'15 rev guidance by $82M at the midpoint to $2,687-2,697M, from $2,600-2,620M, and... More

Hologic (HOLX) Tops Q3 EPS by 4c

July 29, 2015 4:24 PM EDT

Hologic (NASDAQ: HOLX) reported Q3 EPS of $0.43, $0.04 better than the analyst estimate of $0.39. Revenue for the quarter came in at $693.9 million versus the consensus estimate of $654 million.

For earnings history and earnings-related data on Hologic (HOLX) click here.

... More